Stock listing
Cboe Canada:GSD Devonian Health Group, Inc. Stock
Canadian listing (Cboe Canada) of Devonian Health Group, Inc. · home listing TSXV:GSD
Follow Devonian Health Group, Inc. into a list and get an email when it puts out news.
Home listing price · TSXV:GSD
$7.50 CAD +0.75 (+11.1%)
Close on Oct 29, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:GSD
- Day range
- $7.36 – $7.50 CADOct 29, 2026
- Volume
- 278 sharesOct 29, 2026
- Market cap
- $20.86M CADAt the close on Oct 29, 2026 · price × 2.78M shares outstanding
- Traded on an average day
- $18,931 CADMedian day 300 shares · 24 days with no trades · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:GSD · Home | $7.50 CAD | +0.75 (+11.1%) | 278 | $7.36 | $7.50 | $7.36 | $6.75 | Close on Oct 29, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · TSXV:GSD · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.50 | +0.75 | +11.1% | $7.36 | $7.50 | $7.36 | 278 | |
| $6.75 | -0.75 | -10.0% | $7.50 | $7.50 | $6.75 | 1,348 | |
| $7.50 | 0.00 | 0.0% | $7.50 | $7.50 | $7.50 | 100 | |
| $7.50 | +0.40 | +5.6% | $7.50 | $7.50 | $7.50 | 1,107 | |
| $7.10 | 0.00 | 0.0% | $7.10 | $7.10 | $7.10 | 0 | |
| $7.10 | 0.00 | 0.0% | $7.10 | $7.10 | $7.10 | 0 | |
| $7.10 | 0.00 | 0.0% | $7.10 | $7.10 | $7.10 | 0 | |
| $7.10 | 0.00 | 0.0% | $7.10 | $7.10 | $7.10 | 0 | |
| $7.10 | -0.40 | -5.3% | $7.10 | $7.10 | $7.10 | 500 | |
| $7.50 | 0.00 | 0.0% | $7.50 | $7.50 | $7.50 | 0 | |
| $7.50 | -0.50 | -6.3% | $7.50 | $7.50 | $7.50 | 4,500 | |
| $8.00 | -0.25 | -3.0% | $7.50 | $8.00 | $7.50 | 10,200 | |
| $8.25 | +0.25 | +3.1% | $8.25 | $8.25 | $8.25 | 11,200 | |
| $8.00 | +0.50 | +6.7% | $8.00 | $8.00 | $8.00 | 6,900 | |
| $7.50 | +0.80 | +11.9% | $7.50 | $7.50 | $7.50 | 100 | |
| $6.70 | -1.30 | -16.2% | $7.01 | $7.01 | $6.70 | 5,500 | |
| $8.00 | 0.00 | 0.0% | $8.00 | $8.00 | $8.00 | 13,100 | |
| $8.00 | -0.20 | -2.4% | $8.01 | $8.01 | $8.00 | 7,600 | |
| $8.20 | -0.75 | -8.4% | $8.20 | $8.20 | $8.20 | 2,200 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | 0.00 | 0.0% | $8.95 | $8.95 | $8.95 | 0 | |
| $8.95 | +0.32 | +3.7% | $8.25 | $8.95 | $8.25 | 7,600 | |
| $8.63 | 0.00 | 0.0% | $8.63 | $8.63 | $8.63 | 0 | |
| $8.63 | 0.00 | 0.0% | $8.63 | $8.63 | $8.63 | 0 | |
| $8.63 | 0.00 | 0.0% | $8.63 | $8.63 | $8.63 | 0 | |
| $8.63 | +0.005 | +0.1% | $8.63 | $8.63 | $8.63 | 0 | |
| $8.625 | -0.375 | -4.2% | $8.01 | $9.00 | $8.01 | 7,200 | |
| $9.00 | +1.00 | +12.5% | $9.00 | $9.00 | $9.00 | 100 | |
| $8.00 | 0.00 | 0.0% | $8.00 | $8.00 | $8.00 | 0 | |
| $8.00 | -0.01 | -0.1% | $8.00 | $8.00 | $8.00 | 300 | |
| $8.01 | +0.02 | +0.3% | $9.00 | $9.00 | $8.01 | 700 | |
| $7.99 | -1.82 | -18.6% | $8.01 | $8.01 | $7.99 | 1,800 | |
| $9.81 | 0.00 | 0.0% | $9.81 | $9.81 | $9.81 | 0 | |
| $9.81 | 0.00 | 0.0% | $9.81 | $9.81 | $9.81 | 0 | |
| $9.81 | +0.81 | +9.0% | $9.81 | $9.81 | $9.81 | 800 | |
| $9.00 | -0.10 | -1.1% | $9.00 | $9.00 | $9.00 | 800 | |
| $9.10 | -0.65 | -6.7% | $9.75 | $10.15 | $9.10 | 6,800 | |
| $9.75 | -1.25 | -11.4% | $9.01 | $10.00 | $9.00 | 6,100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 1,000 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | -0.35 | -3.1% | $11.00 | $11.00 | $11.00 | 3,600 | |
| $11.35 | +0.15 | +1.3% | $11.49 | $11.50 | $11.00 | 10,000 | |
| $11.20 | -0.80 | -6.7% | $11.20 | $11.20 | $11.20 | 3,300 | |
| $12.00 | +0.85 | +7.6% | $10.15 | $12.00 | $10.15 | 7,500 | |
| $11.15 | +1.05 | +10.4% | $11.15 | $11.15 | $11.15 | 2,100 | |
| $10.10 | +2.15 | +27.0% | $8.50 | $10.15 | $8.50 | 3,700 | |
| $7.95 | 0.00 | 0.0% | $7.95 | $7.95 | $7.95 | 0 | |
| $7.95 | +0.20 | +2.6% | $7.74 | $7.95 | $7.45 | 700 | |
| $7.75 | 0.00 | 0.0% | $7.75 | $7.75 | $7.75 | 0 | |
| $7.75 | 0.00 | 0.0% | $7.75 | $7.75 | $7.75 | 300 | |
| $7.75 | 0.00 | 0.0% | $8.60 | $8.60 | $7.75 | 200 | |
| $7.75 | 0.00 | 0.0% | $7.75 | $7.75 | $7.75 | 0 | |
| $7.75 | -0.75 | -8.8% | $7.75 | $7.75 | $7.75 | 500 | |
| $8.50 | 0.00 | 0.0% | $8.50 | $8.50 | $8.50 | 0 | |
| $8.50 | +0.50 | +6.3% | $8.52 | $8.80 | $8.00 | 1,100 | |
| $8.00 | -2.14 | -21.1% | $9.96 | $9.96 | $8.00 | 1,700 | |
| $10.14 | 0.00 | 0.0% | $10.14 | $10.14 | $10.14 | 0 | |
| $10.14 | +0.89 | +9.6% | $10.14 | $10.14 | $10.14 | 300 | |
| $9.25 | +0.75 | +8.8% | $9.27 | $9.27 | $9.25 | 400 |
- Ticker
- Cboe Canada:GSD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Oct 20, 2026
Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine(TM) Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 27 slides
Latest news
Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine(TM) Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
Oct 20, 2026
Closed $7.10 (0.0%) on Oct 20, 2026
Devonian Health Group Provides Update on its Planned NYSE American Listing
Oct 16, 2026
Closed $7.10 (-5.3%) on Oct 16, 2026
Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American
Sep 11, 2026
Closed $9.00 (+12.5%) on Sep 14, 2026
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
Sep 1, 2026
Closed $9.00 (-1.1%) on Sep 1, 2026
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
Jul 27, 2026
Closed $8.50 (+13.3%) on Jul 27, 2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
Jul 21, 2026
Closed $7.75 (-13.9%) on Jul 21, 2026
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
Jun 30, 2026
Closed $8.14 (-12.0%) on Jun 30, 2026
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
Mar 25, 2026
Closed $12.00 (0.0%) on Mar 26, 2026
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
Feb 19, 2026
Closed $14.00 (0.0%) on Feb 19, 2026
Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
Feb 17, 2026
Closed $13.45 (-3.9%) on Feb 17, 2026
Financings
Public offering of common shares and warrants
Oct 16, 2026
Update: ThinkEquity
Dealers: ThinkEquity (lead)
Announced Jul 27, 2026 · Update Aug 18, 2026 · Update Sep 11, 2026 · Update Oct 16, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 27 slides · July 2026
Investor Presentation (January 2025)
Investor deck · 36 slides · Jan 6, 2025
Investor Presentation (July 2024)
Investor deck · 33 slides · July 2024
Shareholder Meeting (February 2024)
Shareholder meeting · 27 slides · Feb 20, 2024
Devonian Health Group, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 35 in all · newest Oct 20, 2026 · oldest 2017
- Decks
- 9 decks · latest July 2026
Where Devonian Health Group, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:GSD · Home listing | TSXV | Canada | CAD |
| OTC:DVHGF | OTC | United States | USD |
| Cboe Canada:GSD · This page | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about Devonian Health Group, Inc.